Riskpilot← Back to searchSign inGet full accessCOLOSSEUMKLINIKKEN AS
ASActiveOrg 913503880Dental practice care activities · NACE 8623Est. 20140 employeeswww.plakk.no
Revenue 2021
NOK 6,2M
+12% vs 2020
EBITDA margin
35.9%
-11% vs 2020
Equity ratio
1.1%
Financial strength
Net profit 2021
NOK 1,6M
-17% vs 2020
| Revenue | NOK 6,2M | +12% |
| EBITDA | NOK 2,2M | -11% |
| Net profit | NOK 1,6M | -17% |
| Total assets | NOK 2,8M | -16% |
| Equity | NOK 30K | +0% |
| Employees | 0 | — |
Legal name
COLOSSEUMKLINIKKEN AS
Org number
913503880
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
14. april 2014
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Drive tannlegepraksis og hva som naturlig hører under dette.
Address
Phone
+4722838170
Email
gabriel@plakk.no
Website
www.plakk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5 457 | 5 273 | 4 780 | 5 512 | 6 199 |
| Staff expenses | −2 061 | −1 577 | −1 623 | −1 501 | −1 818 |
| EBITDA | 1 843 | 2 339 | 1 475 | 2 504 | 2 224 |
| Depreciation & amort. | −166 | −116 | −31 | −54 | −173 |
| EBIT | 1 678 | 2 222 | 1 444 | 2 449 | 2 051 |
| Net financials | 10 | 11 | 15 | 0 | −11 |
| Profit before tax | 1 687 | 2 234 | 1 458 | 2 450 | 2 040 |
| Tax | 410 | 518 | 323 | 539 | 450 |
| Net profit | 1 278 | 1 715 | 1 136 | 1 911 | 1 591 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 2 086 | 2 605 | 1 791 | 3 367 | 2 843 |
| Equity | 31 | 30 | 30 | 30 | 30 |
| Long-term debt | 0 | 0 | 0 | 414 | 278 |
| Short-term debt | 2 055 | 2 575 | 1 761 | 2 923 | 2 536 |
| Total debt | 2 055 | 2 575 | 1 761 | 3 337 | 2 813 |
EBITDA margin
35.9%
This company
15.8%
Market median
+127% vs market
20172021
Equity ratio
1.1%
This company
38.2%
Market median
-97% vs market
20172021
Return on equity
5302.7%
This company
18.4%
Market median
+28719% vs market
20172021
Net profit margin
25.7%
This company
8.1%
Market median
+217% vs market
20172021
Asset turnover
2.18×
This company
1.12×
Market median
+95% vs market
20172021
Debt / equity
93.77×
This company
0.62×
Market median
-15024% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2014 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of COLOSSEUMKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Evy Maria Grundström | Chief Executive Officer | 0 companies |
| Pål Mørkved | Chairman | 0 companies |
| Gabriel Lorenzo Morales | Chairman | 0 companies |